Latest Breaking News On - Analyst recommendations for longboard pharmaceuticals - Page 1 : comparemela.com

Longboard Pharmaceuticals (LBPH) Buy Rating Reiterated at HC Wainwright

Longboard Pharmaceuticals (LBPH) Buy Rating Reiterated at HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdBourgeon capital managementLongboard pharmaceuticalsTd asset management incLongboard pharmaceuticals stock performanceDenali advisorsNews ratings for longboard pharmaceuticals dailyAnalyst recommendations for longboard pharmaceuticalsCantor fitzgeraldSg americas securitiesLongboard pharmaceuticals incLongboard pharmaceuticals company profileGet free reportCapital managementManagement incLongboard pharmaceuticals daily

HC Wainwright Reiterates Buy Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)

HC Wainwright Reiterates Buy Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdBourgeon capital managementLongboard pharmaceuticalsSg americas securitiesCantor fitzgeraldLongboard pharmaceuticals company profileInstitutional investors weigh in on longboard pharmaceuticalsLongboard pharmaceuticals incAsset management incLongboard pharmaceuticals stockAnalyst recommendations for longboard pharmaceuticalsDenali advisorsNews ratings for longboard pharmaceuticals dailyGet free reportCapital managementManagement inc

Cantor Fitzgerald Reaffirms Overweight Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)

Cantor Fitzgerald Reaffirms Overweight Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdTd asset management incAnalyst recommendations for longboard pharmaceuticalsBourgeon capital managementLongboard pharmaceuticalsJennison associatesHedge funds weigh in on longboard pharmaceuticalsAsset management incCantor fitzgeraldNews ratings for longboard pharmaceuticals dailyLongboard pharmaceuticals trading downLongboard pharmaceuticals incPolar capital holdings plcFree reportPharmaceuticals trading downGet free report

Wedbush Raises Longboard Pharmaceuticals (NASDAQ:LBPH) Price Target to $34 00

Wedbush Raises Longboard Pharmaceuticals (NASDAQ:LBPH) Price Target to $34 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdDenali advisorsAsset management incCantor fitzgeraldNews ratings for longboard pharmaceuticals dailyLongboard pharmaceuticals incAnalyst recommendations for longboard pharmaceuticalsJennison associatesLongboard pharmaceuticalsPlatinum investment management ltdLongboard pharmaceuticals price performanceInstitutional investors weigh in on longboard pharmaceuticalsParkman healthcare partnersFree reportGet free reportHealthcare partners

Cantor Fitzgerald Reiterates Overweight Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)

Longboard Pharmaceuticals (NASDAQ:LBPH – Get Free Report)‘s stock had its “overweight” rating reiterated by investment analysts at Cantor Fitzgerald in a research note issued on Friday, Benzinga reports. They currently have a $60.00 target price on the stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 178.68% from the company’s current price. Other […]

Robertw bairdLongboard pharmaceuticals stock performanceLongboard pharmaceuticalsParkman healthcare partnersLongboard pharmaceuticals company profileTd asset management incCantor fitzgeraldAnalyst recommendations for longboard pharmaceuticalsBourgeon capital managementNews ratings for longboard pharmaceuticals dailyDenali advisorsLongboard pharmaceuticals incAsset management incHedge funds weigh in on longboard pharmaceuticalsGet free reportCapital management